Your browser doesn't support javascript.
loading
Looking ahead to targeting macrophages by CAR T- or NK-cells in blood cancers.
Kegyes, David; Milea, Paul Alexandru; Mazga, Andreea-Isabella; Tigu, Adrian-Bogdan; Nistor, Madalina; Cenariu, Diana; Tomai, Radu; Buruiana, Sanda; Einsele, Hermann; Daniela Tanase, Alina; Tomuleasa, Ciprian.
Afiliación
  • Kegyes D; Department of Hematology/Medfuture Research Center for Advanced Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Milea PA; Department of Hematology/Medfuture Research Center for Advanced Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Mazga AI; Department of Hematology/Medfuture Research Center for Advanced Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Tigu AB; Department of Hematology/Medfuture Research Center for Advanced Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Nistor M; Department of Hematology/Medfuture Research Center for Advanced Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Cenariu D; Department of Hematology/Medfuture Research Center for Advanced Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Tomai R; Department of Hematology, Ion Chiricuta Cancer Center, Cluj-Napoca, Romania.
  • Buruiana S; Department of Hematology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Moldova.
  • Einsele H; Department of Hematology/Medfuture Research Center for Advanced Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Daniela Tanase A; Department of Internal Medicine II, Hematology, University Hospital Würzburg, Würzburg, Germany.
  • Tomuleasa C; Department of Stem Cell Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
Expert Opin Ther Targets ; 28(9): 779-787, 2024 Sep.
Article en En | MEDLINE | ID: mdl-39235181
ABSTRACT

INTRODUCTION:

The bone marrow microenvironment (BME) is critical for healthy hematopoiesis and is often disrupted in hematologic malignancies. Tumor-associated macrophages (TAMs) are a major cell type in the tumor microenvironment (TME) and play a significant role in tumor growth and progression. Targeting TAMs and modulating their polarization is a promising strategy for cancer therapy. AREAS COVERED In this review, we discuss the importance of TME and different multiple possible targets to modulate immunosuppressive TAMs such as CD123, Sphingosine 1-Phosphate Receptors, CD19/CD1d, CCR4/CCL22, CSF1R (CD115), CD24, CD40, B7 family proteins, MARCO, CD47, CD163, CD204, CD206 and folate receptors. EXPERT OPINION Innovative approaches to combat the immunosuppressive milieu of the tumor microenvironment in hematologic malignancies are of high clinical significance and may lead to increased survival, improved quality of life, and decreased toxicity of cancer therapies. Standard procedures will likely involve a combination of CAR T/NK-cell therapies with other treatments, leading to more comprehensive cancer care.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Inmunoterapia Adoptiva / Neoplasias Hematológicas / Microambiente Tumoral / Receptores Quiméricos de Antígenos / Macrófagos Asociados a Tumores Límite: Animals / Humans Idioma: En Revista: Expert Opin Ther Targets Asunto de la revista: TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: Rumanía Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Inmunoterapia Adoptiva / Neoplasias Hematológicas / Microambiente Tumoral / Receptores Quiméricos de Antígenos / Macrófagos Asociados a Tumores Límite: Animals / Humans Idioma: En Revista: Expert Opin Ther Targets Asunto de la revista: TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: Rumanía Pais de publicación: Reino Unido